Stock RGLS REGULUS THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Regulus Therapeutics Inc.

Equities

RGLS

US75915K3095

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-08 EDT 		5-day change 1st Jan Change
2.27 USD +1.79% Intraday chart for Regulus Therapeutics Inc. -9.56% +77.34%
05-06 Regulus Therapeutics Advances to Cohort 4 of Phase 1B Multiple-Ascending Dose Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease CI
03-21 Regulus Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RGLS Stock
  4. News Regulus Therapeutics Inc.
  5. MarketScreener Strategies
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW